10 years ago - the poet and the potions


Taking up a challenge from the other RSC - the Royal Shakespeare Company - which was launching a production of Shakespeare's A Midsummer Night's Dream, the RSC (the chemistry one) approached Quest International with the task of recreating the love potion which causes Titania, queen of the fairies, to fall in love with the first person she sees.

Shakespeare mentions 'a little western flower, before milk-white, now purple with love's wound and maidens call it love-in-idleness'. Love-in-idleness is an old folk name for wild pansy (Viola tricolor), which has long been used as a herbal remedy. Using this flower as the main ingredient, the researchers at Quest then added a range of other flowery fragrances to create the final elixir, which has been termed Puck's potion.

Charles Sell, head of organic chemistry at Quest, said: 'There are scores of references to plants and herbs in Shakespeare, who was obviously very knowledgeable about their real and mythical potency'.

Chemistry in Britain (2002)


Related Content

Flashback

28 March 2012 Premium contentFlashback

news image

10 years ago

Dial chem for murder

6 March 2015 The Crucible

news image

Poisons may seem to be a murderer’s perfect accomplice, but chemists can always persuade them to betray their secrets, says...

Most Read

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Chemists zinc up ‘aromatic’ metal cubes

2 March 2015 Research

news image

Metal-organic clusters share electrons between eight covalently linked metal atoms

Most Commented

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Hepatitis C drug patent challenged in Europe

19 February 2015 Business

news image

Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent